登革热：持续的全球威胁。
Dengue: a continuing global threat.
机构信息
Instituto de Medicina Tropical, 'Pedro Kouri', PO Box 601, Marianao 13, Ciucad de la Habana, Cuba.
出版信息
Nat Rev Microbiol. 2010 Dec;8(12 Suppl):S7-16. doi: 10.1038/nrmicro2460.
Abstract
Dengue fever and dengue haemorrhagic fever are important arthropod-borne viral diseases. Each year, there are ∼50 million dengue infections and ∼500,000 individuals are hospitalized with dengue haemorrhagic fever, mainly in Southeast Asia, the Pacific and the Americas. Illness is produced by any of the four dengue virus serotypes. A global strategy aimed at increasing the capacity for surveillance and outbreak response, changing behaviours and reducing the disease burden using integrated vector management in conjunction with early and accurate diagnosis has been advocated. Antiviral drugs and vaccines that are currently under development could also make an important contribution to dengue control in the future.
摘要
登革热和登革出血热是重要的虫媒病毒病。每年，约有 5000 万例登革热感染病例，约有 50 万人因登革出血热住院，主要集中在东南亚、太平洋和美洲。这四种登革热病毒血清型都可引起疾病。目前提倡采取一项全球战略，通过综合病媒管理，结合早期和准确的诊断，来提高监测和疫情应对能力、改变行为以及减轻疾病负担。目前正在开发的抗病毒药物和疫苗也将对未来的登革热控制做出重要贡献。
相似文献
1
Dengue: a continuing global threat.登革热：持续的全球威胁。
Nat Rev Microbiol. 2010 Dec;8(12 Suppl):S7-16. doi: 10.1038/nrmicro2460.
2
Dengue epidemiology: virus epidemiology, ecology, and emergence.登革热流行病学：病毒流行病学、生态学与新出现情况。
Adv Virus Res. 2003;61:235-89. doi: 10.1016/s0065-3527(03)61006-7.
3
Dengue fever in the Western Hemisphere.西半球的登革热。
Clin Lab Sci. 2003 Winter;16(1):34-8.
4
The changing epidemiology of yellow fever and dengue, 1900 to 2003: full circle?1900年至2003年黄热病和登革热流行病学的变化：兜了一圈又回到原点？
Comp Immunol Microbiol Infect Dis. 2004 Sep;27(5):319-30. doi: 10.1016/j.cimid.2004.03.013.
5
Best practices in dengue surveillance: a report from the Asia-Pacific and Americas Dengue Prevention Boards.登革热监测最佳实践：来自亚太和美洲登革热预防理事会的报告。
PLoS Negl Trop Dis. 2010 Nov 16;4(11):e890. doi: 10.1371/journal.pntd.0000890.
6
Dengue virus.登革病毒
Clin Lab Med. 2010 Mar;30(1):149-60. doi: 10.1016/j.cll.2009.10.007.
7
Increasing airline travel may facilitate co-circulation of multiple dengue virus serotypes in Asia.航空旅行的增加可能会促进多种登革热病毒血清型在亚洲的共同传播。
PLoS Negl Trop Dis. 2017 Aug 3;11(8):e0005694. doi: 10.1371/journal.pntd.0005694. eCollection 2017 Aug.
8
Outwitting dengue threat and epidemics resurgence in Asia-Pacific countries: strengthening integrated dengue surveillance, monitoring and response systems.智胜登革热威胁及亚太国家登革热疫情死灰复燃：加强登革热综合监测、监控及应对系统
Infect Dis Poverty. 2016 May 27;5(1):56. doi: 10.1186/s40249-016-0148-3.
9
History, epidemiology and diagnostics of dengue in the American and Brazilian contexts: a review.美巴两国登革热的历史、流行病学和诊断：综述。
Parasit Vectors. 2018 Apr 24;11(1):264. doi: 10.1186/s13071-018-2830-8.
10
Epidemiological update on the dengue situation in the Western Pacific Region, 2012.2012年西太平洋区域登革热疫情最新情况
Western Pac Surveill Response J. 2015 Apr 20;6(2):82-9. doi: 10.5365/WPSAR.2014.5.4.002. eCollection 2015 Apr-Jun.
引用本文的文献
1
Forecasting Dengue: Evaluating the Role of Hydroclimate Information in Subseasonal to Seasonal Prediction.登革热预测：评估水文气候信息在次季节到季节预测中的作用。
Geohealth. 2025 Sep 1;9(9):e2024GH001325. doi: 10.1029/2024GH001325. eCollection 2025 Sep.
2
Recapitulating dengue virus infection with human pluripotent stem cell-derived liver organoids for antiviral screening.利用人多能干细胞衍生的肝脏类器官重现登革病毒感染以进行抗病毒筛选。
Nat Commun. 2025 Aug 28;16(1):8069. doi: 10.1038/s41467-025-63323-3.
3
Mining of the Streptome Database for Hunting Putative Candidates to Allosterically Inhibit the Dengue Virus (Serotype 2) RdRp.挖掘链霉菌数据库以寻找可别构抑制登革病毒（血清型2）RNA依赖的RNA聚合酶的潜在候选物。
Pharmaceuticals (Basel). 2025 Jul 30;18(8):1135. doi: 10.3390/ph18081135.
4
and dengue: insights into transmission dynamics and viral lifecycle.以及登革热：对传播动力学和病毒生命周期的见解。
Epidemiol Infect. 2025 Aug 1;153:e88. doi: 10.1017/S0950268825100320.
5
Comparative analysis of phytocompounds and repurposed drugs against dengue virus serotypes employing an in silico study.采用计算机模拟研究对登革病毒血清型的植物化合物和重新利用的药物进行比较分析。
Sci Rep. 2025 Jul 30;15(1):27878. doi: 10.1038/s41598-025-06974-y.
6
Contrasted Ethnobotanical and Literature Knowledge of Anti-Mosquito Plants from Guadeloupe.瓜德罗普岛抗蚊植物的民族植物学知识与文献知识对比
Biology (Basel). 2025 Jul 19;14(7):888. doi: 10.3390/biology14070888.
7
Seroprevalence of dengue virus infection among febrile patients visiting healthcare facilities in the selected districts of Afar region, Northeast Ethiopia.埃塞俄比亚东北部阿法尔地区选定地区前往医疗机构就诊的发热患者中登革热病毒感染的血清流行率。
BMC Infect Dis. 2025 Jul 28;25(1):948. doi: 10.1186/s12879-025-11406-3.
8
Sensitivity and Cross-Reactivity Analysis of Serotype-Specific Anti-NS1 Serological Assays for Dengue Virus Using Optical Modulation Biosensing.利用光调制生物传感技术对登革病毒血清型特异性抗NS1血清学检测方法进行敏感性和交叉反应性分析
Biosensors (Basel). 2025 Jul 14;15(7):453. doi: 10.3390/bios15070453.
9
Pharmacological Evaluation of active compounds in papaya associated with thrombocytopenia inhibition in dengue patients through in silico approaches.通过计算机模拟方法对番木瓜中与登革热患者血小板减少抑制相关的活性化合物进行药理学评估。
Sci Rep. 2025 Jul 24;15(1):26922. doi: 10.1038/s41598-025-09835-w.
10
Molecular Epidemiology and evolutionary characteristics of dengue virus serotype-2 strains in Sri Lanka.斯里兰卡登革热病毒2型毒株的分子流行病学及进化特征
Res Sq. 2025 Jun 29:rs.3.rs-6726277. doi: 10.21203/rs.3.rs-6726277/v1.
本文引用的文献
1
The human immune response to Dengue virus is dominated by highly cross-reactive antibodies endowed with neutralizing and enhancing activity.人类对登革病毒的免疫反应主要由具有中和和增强活性的高度交叉反应性抗体主导。
Cell Host Microbe. 2010 Sep 16;8(3):271-83. doi: 10.1016/j.chom.2010.08.007.
2
Cross-reacting antibodies enhance dengue virus infection in humans.交叉反应抗体增强了人类感染登革热病毒的能力。
Science. 2010 May 7;328(5979):745-8. doi: 10.1126/science.1185181.
3
Recent expansion of dengue virus serotype 3 in West Africa.西非登革热病毒 3 型的近期扩张。
Euro Surveill. 2010 Feb 18;15(7):19490.
4
A novel tetravalent dengue vaccine is well tolerated and immunogenic against all 4 serotypes in flavivirus-naive adults.一种新型四价登革热疫苗在黄病毒初免成人中具有良好的耐受性和针对所有 4 种血清型的免疫原性。
J Infect Dis. 2010 Feb 1;201(3):370-7. doi: 10.1086/649916.
5
Phase 1 trial of the dengue virus type 4 vaccine candidate rDEN4{Delta}30-4995 in healthy adult volunteers.登革热病毒4型候选疫苗rDEN4{Delta}30 - 4995在健康成年志愿者中的1期试验。
Am J Trop Med Hyg. 2009 Nov;81(5):834-41. doi: 10.4269/ajtmh.2009.09-0131.
6
Dengue plaque reduction neutralization test (PRNT) in primary and secondary dengue virus infections: How alterations in assay conditions impact performance.原发性和继发性登革病毒感染中的登革热蚀斑减少中和试验（PRNT）：检测条件的改变如何影响检测性能。
Am J Trop Med Hyg. 2009 Nov;81(5):825-33. doi: 10.4269/ajtmh.2009.08-0625.
7
Evaluation of commercially available anti-dengue virus immunoglobulin M tests.市售抗登革病毒免疫球蛋白M检测的评估
Emerg Infect Dis. 2009 Mar;15(3):436-40. doi: 10.3201/eid1503.080923.
8
Guidelines for Plaque-Reduction Neutralization Testing of Human Antibodies to Dengue Viruses.登革病毒人源抗体噬斑减少中和试验指南
Viral Immunol. 2008 Jun;21(2):123-32. doi: 10.1089/vim.2008.0007.
9
Levels of insecticide resistance and resistance mechanisms in Aedes aegypti from some Latin American countries.一些拉丁美洲国家埃及伊蚊的杀虫剂抗性水平及抗性机制
J Am Mosq Control Assoc. 2007 Dec;23(4):420-9. doi: 10.2987/5588.1.
10
Dengue virus-mosquito interactions.登革热病毒与蚊子的相互作用。
Annu Rev Entomol. 2008;53:273-91. doi: 10.1146/annurev.ento.53.103106.093326.
Zotero 插件